Why the study?
Does SG-75 prevent methacholine-induced ECG changes and coronary vasoconstriction in rat models of angina pectoris?
Does SG-75 prevent methacholine-induced ECG changes and coronary vasoconstriction in rat models of angina pectoris?
Answers are grounded in this paper and cite their sources.
SG-75 (Nicorandil) demonstrates spasmolytic action by preventing methacholine-induced coronary vasoconstriction and associated ECG changes in rat models, unlike papaverine.
The effects of a newly developed nicotinamide derivative, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75, Nicorandil), were examined in an experimental model of angina pectoris, utilizing methacholine-induced ECG changes as main parameter in intact anesthetized rats. The right carotid artery was exposed and through it a special cannula was inserted to a point near the right and left coronary ostium. Such a device made it possible to inject drugs more selectively into the coronary artery. Single intra-aortic injections of 4 to 8 μg of methacholine caused a transient elevation of the ST segment and T wave of the electrocardiogram (ECG). SG-75 (3 mg/kg i.v. or 10 mg/kg p.o.) prevented these changes in the ECG, while a potent vasodilator, papaverine, failed to do so. In the isolated, donor-perfused rat heart, SG-75 (1-30 μg) injected into the coronary perfusion system caused dose-dependent vasodilation, while 0.1-0.8 μg acetylcholine as well as methacholine produced marked vasoconstriction. SG-75 (10 mg/kg) administered orally to the donor rat inhibited the coronary vasoconstriction produced by the cholinomimetic drugs, whereas papaverine (30 μg i.a.) failed to prevent it. The inhibitory effects of SG-75 on methacholine-induced ECG changes in intact rats seemed to be due to its spasmolytic action.
No takes yet. Share an insight, caveat, or question.
Aono et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: